These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 10721499)

  • 21. Comorbidity between post-traumatic stress disorder and borderline personality disorder: a review.
    Frías Á; Palma C
    Psychopathology; 2015; 48(1):1-10. PubMed ID: 25227722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insecure Attachment Styles and Increased Borderline Personality Organization in Substance Use Disorders.
    Hiebler-Ragger M; Unterrainer HF; Rinner A; Kapfhammer HP
    Psychopathology; 2016; 49(5):341-344. PubMed ID: 27631792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance use and borderline personality disorder: fostering hope in the face of complexity.
    Donald F; Arunogiri S; Lubman DI
    Australas Psychiatry; 2019 Dec; 27(6):569-572. PubMed ID: 31512481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Borderline personality and substance use in women.
    Feske U; Tarter RE; Kirisci L; Pilkonis PA
    Am J Addict; 2006; 15(2):131-7. PubMed ID: 16595350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of interventions for co-occurring substance use disorder and borderline personality disorder.
    Pennay A; Cameron J; Reichert T; Strickland H; Lee NK; Hall K; Lubman DI
    J Subst Abuse Treat; 2011 Dec; 41(4):363-73. PubMed ID: 21742460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Association Between Illicit Drug Use, Borderline Personality Disorder and Depression in a Help-Seeking Sample of Adolescents].
    Ghinea D; Parzer P; Resch F; Kaess M; Edinger A
    Prax Kinderpsychol Kinderpsychiatr; 2020 Mar; 69(2):126-140. PubMed ID: 32114950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three clinical indicators of borderline personality disorder in anorexia nervosa: A pilot study.
    Danon M; Duriez P; Gorwood P
    Encephale; 2024 Feb; 50(1):4-10. PubMed ID: 36411120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with co-occurring borderline personality disorder among inner-city substance users: the roles of childhood maltreatment, negative affect intensity/reactivity, and emotion dysregulation.
    Gratz KL; Tull MT; Baruch DE; Bornovalova MA; Lejuez CW
    Compr Psychiatry; 2008; 49(6):603-15. PubMed ID: 18970909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impulsivity and risk-taking in borderline personality disorder with and without substance use disorders.
    Coffey SF; Schumacher JA; Baschnagel JS; Hawk LW; Holloman G
    Personal Disord; 2011 Apr; 2(2):128-41. PubMed ID: 22448732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comorbidity in patients with narcissistic personality disorder in comparison to patients with borderline personality disorder].
    Ritter K; Roepke S; Merkl A; Heuser I; Fydrich T; Lammers CH
    Psychother Psychosom Med Psychol; 2010 Jan; 60(1):14-24. PubMed ID: 19235677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention.
    Black DW; Blum N; Pfohl B; Hale N
    J Pers Disord; 2004 Jun; 18(3):226-39. PubMed ID: 15237043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance abuse patterns and their association with psychopathology and type of hostility in male patients with borderline and antisocial personality disorder.
    Hatzitaskos P; Soldatos CR; Kokkevi A; Stefanis CN
    Compr Psychiatry; 1999; 40(4):278-82. PubMed ID: 10428187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of borderline personality disorder on residential substance abuse treatment dropout among men.
    Tull MT; Gratz KL
    Drug Alcohol Depend; 2012 Feb; 121(1-2):97-102. PubMed ID: 21907503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Borderline personality disorder and substance abuse: consequences of comorbidity.
    Links PS; Heslegrave RJ; Mitton JE; van Reekum R; Patrick J
    Can J Psychiatry; 1995 Feb; 40(1):9-14. PubMed ID: 7874683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of substance use disorder on treatment process and outcome in a ten-session psychiatric treatment for borderline personality disorder.
    Penzenstadler L; Kolly S; Rothen S; Khazaal Y; Kramer U
    Subst Abuse Treat Prev Policy; 2018 Feb; 13(1):10. PubMed ID: 29482597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance use in borderline personality disorder.
    Dulit RA; Fyer MR; Haas GL; Sullivan T; Frances AJ
    Am J Psychiatry; 1990 Aug; 147(8):1002-7. PubMed ID: 2375433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminant efficiency of antisocial and borderline personality disorder criteria in Hispanic men with substance use disorders.
    Becker DF; Grilo CM; Anez LM; Paris M; McGlashan TH
    Compr Psychiatry; 2005; 46(2):140-6. PubMed ID: 15723032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Borderline diagnosis and substance abuse in female patients with eating disorders.
    Koepp W; Schildbach S; Schmager C; Rohner R
    Int J Eat Disord; 1993 Jul; 14(1):107-10. PubMed ID: 8339092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring Attachment Patterns in Patients With Comorbid Borderline Personality and Substance Use Disorders.
    Schindler A; Sack PM
    J Nerv Ment Dis; 2015 Nov; 203(11):820-6. PubMed ID: 26488917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axis II comorbidity of borderline personality disorder in adolescents.
    Loas G; Pham-Scottez A; Cailhol L; Perez-Diaz F; Corcos M; Speranza M
    Psychopathology; 2013; 46(3):172-5. PubMed ID: 23006475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.